Probing Tumour Proteostasis and the UPR with Serum Markers

Trends in Cancer

Volumn 2, Issue 5, 2016, Pages 219-221

  Galmiche, Antoine ^a,b   Sauzay, Chloé ^a,b   Houessinon, Aline ^a,b   Chauffert, Bruno ^a,b   Pluquet, Olivier ^c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c UNIV LILLE   (France)

Author keywords

serum tumour markers; therapeutics; tumour proteostasis; UPR

Indexed keywords

MARKER; TUMOR PROTEIN; BIOLOGICAL MARKER;

CANCER THERAPY; HUMAN; PROTEIN HOMEOSTASIS; REVIEW; TUMOR GROWTH; UNFOLDED PROTEIN RESPONSE; BLOOD; METABOLISM; NEOPLASM;

BIOMARKERS; HUMANS; NEOPLASMS; PROTEOSTASIS; UNFOLDED PROTEIN RESPONSE;

EID: 84968830267     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2016.04.004     Document Type: Short Survey

References (14)

1. D. Sidransky Emerging molecular markers of cancer Nat. Rev. Cancer 2 2002 210 219
2. N. Personeni, and et al. Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma J. Hepatol. 57 2012 101 107
3. M. Wang, and R.J. Kaufman The impact of the endoplasmic reticulum protein-folding environment on cancer development Nat. Rev. Cancer 14 2014 581 597
4. E. Chevet, and et al. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis Cancer Discov. 5 2015 586 597
5. N. Andruska, and et al. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer Oncogene 34 2015 3760 3769
6. M.C. Wielenga, and et al. ER-stress-induced differentiation sensitizes colon cancer stem cells to chemotherapy Cell Rep. 13 2015 489 494
7. C. Hetz, and et al. Targeting the unfolded protein response in disease Nat. Rev. Drug Discov. 12 2013 703 719
8. A. Houessinon, and et al. Alfa-feto protein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib Cancer Lett. 370 2016 242 249
9. M.S. Sosa, and et al. Mechanisms of disseminated cancer cell dormancy: an awakening field Nat. Rev. Cancer 14 2014 611 622
10. A.C. Yeh, and S. Ramaswamy Mechanisms of cancer cell dormancy - another hallmark of cancer? Cancer Res. 75 2015 5014 5022
11. D.M. Schewe, and J.A. Aguirre-Ghiso ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo Proc. Natl. Acad. Sci. U.S.A. 105 2008 10519 10524
12. K. Bartkowiak, and et al. Disseminated tumor cells persist in the bone marrow of breast cancer patients through sustained activation of the unfolded protein response Cancer Res. 75 2015 5367 5377
13. M. Obeid, and et al. Calreticulin exposure dictates the immunogenicity of cancer cell death Nat. Med. 13 2007 54 61
14. N. Chignard, and et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: detection of generated fragments in patient sera Gastroenterology 130 2006 2010 2022